Maribavir for Preemptive Treatment
Maribavir is a benzimidazole riboside with activity against cytomegalovirus (CMV). The safety and efficacy of maribavir for preemptive treatment of CMV infection in transplant recipients is not known. Design adds…
Diabetes Tougher on Women’s Hearts
Diabetes might be more deadly for women than men, at least when it comes to heart troubles, new research shows. Heart disease occurs an average of 15 years earlier in…
Cancer Risk May Rise After Heart Attack
Here's some worrisome news for folks who manage to survive a heart attack: New research suggests they might be far more vulnerable to developing cancer down the road. People who…
New guidelines from the Thrombosis
Introduction: Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), is the third most common cardiovascular disease and, globally, more than an estimated 10 million people have it…
